The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Colonic Diseases

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Colonic Diseases

 

High impact information on Colonic Diseases

  • CONCLUSIONS: Butyrate has dual effects in markedly reducing colonic epithelial urokinase activity, and these may have important implications to understanding colonic epithelial physiology and the pathogenesis and treatment of colonic diseases [6].
  • This high level expression of PPARgamma in colon warrants further study in view of the well established role of fatty acid and arachidonic acid derivatives in colonic disease [7].
  • Thus severe colonic disease noted during the course of DBA/2----B6D2F1 murine GVHD was found to have significant histopathologic similarities to both human GVHD enteropathy and other inflammatory diseases of the human colon [8].
  • However, the consistent association of the deletion at codon 1309 with more severe colonic disease than that observed in patients with mutations at codons 1061 and 1068, supports a correlation between mutation site and penetrance of FAP [9].
  • In conclusion, a fish oil diet prevents the increase in thromboxane in the chronic state of inflammation and shortens the course of the colonic disease by diminishing both the severity of the lesions and their progression to chronicity [10].
 

Chemical compound and disease context of Colonic Diseases

  • A significant correlation was found between 24 and 48 h faecal Indium-111 excretion for small bowel (r = 0.708, p less than 0.0001) and colonic disease (r = 0.994, p less than 0.0001) [11].
  • Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease [12].
  • Of those patients who had colonic gallium activity that did not change in location or intensity during the study, 9 had proved colonic disease [13].
  • Because colonic disease activity and treatment with sulfasalazine have been found to be of independent importance for development of colonic carcinoma in UC, this study aims to determine if differences exist concerning colonic disease activity in UC patients with and without PSC [14].
  • Development of a chronic colonic intubation model in rats for the study of luminal factors in colonic diseases [15].
 

Gene context of Colonic Diseases

  • An association between nonsynonymous variants in the TLR1, -2, and -6 genes and extensive colonic disease in UC and CD was found [16].
  • Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease [17].
  • These results further demonstrate that IL-2 plays a significant role in normal immune responses in the body and that plasma SAA levels both reflect colonic disease severity and may indicate subclinical disease in both IL-2(-/-)and IL-2(+/-)mice [18].
  • In 14 patients with a variety of benign colonic diseases the mean faecal CEA was 7.12 +/- 1.39 micrograms/g which was not significantly different from the mean pre-operative value in the cancer patients [19].
  • The carriage of allele 2 may favour steroid-dependent disease and to a lesser extent fistulizing and colonic disease, possibly secondary to a more intense TNF-alpha-driven inflammatory reaction at the mucosal level [20].

References

  1. Laparoscopic surgery for Crohn's disease: reasons for conversion. Schmidt, C.M., Talamini, M.A., Kaufman, H.S., Lilliemoe, K.D., Learn, P., Bayless , T. Ann. Surg. (2001) [Pubmed]
  2. Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Cahill, R.J., O'Sullivan, K.R., Mathias, P.M., Beattie, S., Hamilton, H., O'Morain, C. Gut (1993) [Pubmed]
  3. Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Shen, W., Steinrück, H., Ljungh, A. Gut (1995) [Pubmed]
  4. Inflammatory bowel disease and cancer. Itzkowitz, S.H. Gastroenterol. Clin. North Am. (1997) [Pubmed]
  5. Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's disease. Arnott, I.D., Drummond, H.E., Ghosh, S. European journal of gastroenterology & hepatology. (2001) [Pubmed]
  6. Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro. Gibson, P.R., Rosella, O., Rosella, G., Young, G.P. Gastroenterology (1994) [Pubmed]
  7. The organization, promoter analysis, and expression of the human PPARgamma gene. Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.M., Saladin, R., Najib, J., Laville, M., Fruchart, J.C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M.R., Staels, B., Vidal, H., Auwerx, J. J. Biol. Chem. (1997) [Pubmed]
  8. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease. Eigenbrodt, M.L., Eigenbrodt, E.H., Thiele, D.L. Am. J. Pathol. (1990) [Pubmed]
  9. Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations. Cama, A., Palmirotta, R., Curia, M.C., Esposito, D.L., Ranieri, A., Ficari, F., Valanzano, R., Battista, P., Modesti, A., Tonelli, F. Hum. Mutat. (1995) [Pubmed]
  10. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Vilaseca, J., Salas, A., Guarner, F., Rodríguez, R., Martínez, M., Malagelada, J.R. Gut (1990) [Pubmed]
  11. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Crama-Bohbouth, G., Pena, A.S., Biemond, I., Verspaget, H.W., Blok, D., Arndt, J.W., Weterman, I.T., Pauwels, E.K., Lamers, C.B. Gut (1989) [Pubmed]
  12. Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Harris, D.W., Smith, P.R., Swan, C.H. Gut (1978) [Pubmed]
  13. Diagnostic significance of persistent colonic gallium activity: scintigraphic patterns. Pechman, R., Tetalman, M., Antonmattei, S., Bekerman, C., Olsen, J., Chiles, J. Radiology. (1978) [Pubmed]
  14. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Lundqvist, K., Broomé, U. Dis. Colon Rectum (1997) [Pubmed]
  15. Development of a chronic colonic intubation model in rats for the study of luminal factors in colonic diseases. Tang, C.L., Wong, C.S., Sengupta, S., Tjandra, J.J., Gibson, P.R. Dis. Colon Rectum (2002) [Pubmed]
  16. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Pierik, M., Joossens, S., Van Steen, K., Van Schuerbeek, N., Vlietinck, R., Rutgeerts, P., Vermeire, S. Inflamm. Bowel Dis. (2006) [Pubmed]
  17. Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease. Galandiuk, S., Miseljic, S., Yang, A.R., Early, M., McCoy, M.D., Wittliff, J.L. Archives of surgery (Chicago, Ill. : 1960) (1993) [Pubmed]
  18. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. de Villiers, W.J., Varilek, G.W., de Beer, F.C., Guo, J.T., Kindy, M.S. Cytokine (2000) [Pubmed]
  19. Faecal carcinoembryonic antigen in colorectal cancer patients. Stubbs, R.S., Nadkarni, D.M., Monsey, H.A. Gut (1986) [Pubmed]
  20. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Louis, E., Peeters, M., Franchimont, D., Seidel, L., Fontaine, F., Demolin, G., Croes, F., Dupont, P., Davin, L., Omri, S., Rutgeerts, P., Belaiche, J. Clin. Exp. Immunol. (2000) [Pubmed]
 
WikiGenes - Universities